astroblastoma

At this point, no literature has indicated whether environmental factors increase the likelihood of astroblastoma.

Most children can continue to lead productive, healthy lives after a low-grade astroblastoma is treated.

Like most tumors in the brain, astroblastoma can be treated through surgery and various forms of therapy.

The use of radiation therapy after an astroblastoma excision has variable results.

However, further histology has confirmed that special structures and characteristics are unique to astroblastoma.

The majority of patients with astroblastoma display a limited set of physical and physiological symptoms.

However, the "bubbly" appearance in astroblastoma is entirely exclusive.

Nausea is seen in almost all cases of astroblastoma, especially in low-grade tumors.

Convulsions are observed in older patients with astroblastoma.

One of the more exciting and promising routes for treatment involves stem cell use to combat astroblastoma.

Malignant astroblastoma distorts the function of surrounding brain regions, and pressure is the primary result.

Nevertheless, a combination of age, anatomic location, and image assessment can efficiently evaluate astroblastoma.

A study in 2005 profiled cell surface markers of astroblastoma cells removed from an 11 year-old patient.

However, the work remains a preliminary insight into the role of neuronal stemlike cells on astroblastoma development.

Beyond normal pathologies, scientists have discovered some abnormal characteristics of astroblastoma in a variety of patients.

Driving behind the wheel is dangerous when astroblastoma grows in residual tissue size, since peripheral vision can be insufficient.

The symptoms listed above are usually strong indicators for astroblastoma, allowing the patient to take necessary precautions as soon as possible.

However, literature confirms that patient may carry a noticeable, low-grade astroblastoma for several years without visible symptoms.

More than other brain tumors, astroblastoma is frequently a recurring tumor; its rate remains high, even after resection as treatment.

Since the early 1890s, astroblastoma has established a stable set of pathological qualities that truly distinguishes itself as a separate and significant entity.

An enormous difficulty lies in classifying an astroblastoma tumor due to its overlapping features with other brain tumors.

The likelihood of low-grade astroblastoma returning after surgery is highly improbable, but some patients have exhibited recurrence.

Radiation therapy selectively kills astroblastoma cells while leaving surrounding normal brain tissue unharmed.

Specific neuronal markers further distinguish astroblastoma.

In other instances, physicians will deem an astroblastoma simply a "brain mass," referring cases towards certified oncologists.